In Lebanon, the people living with hiv antiretroviral therapy coverage stands at 80%, reflecting an increase of 8% (11.1%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Lebanon
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Lebanon
Antiretroviral therapy coverage
More indicators for Lebanon
Male unintentional poisoning
0.7
+0.1
(2019)
Female wasting in children
1.4%
-4%
(2021)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar183
-intl dollar90
(2021)
Birth registration
98.9%
-0.6%
(2016)
Contraceptive modern method prevalence
46.8%
+12.6%
(2009)
Lebanon Antiretroviral therapy coverage between 2000 and 2022
| Period | Antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 80% | +8% |
| 2021 | 72% | +4% |
| 2020 | 68% | +5% |
| 2019 | 63% | +11% |
| 2018 | 52% | +8% |
| 2017 | 44% | +7% |
| 2016 | 37% | +7% |
| 2015 | 30% | +4% |
| 2014 | 26% | +1% |
| 2013 | 25% | -2% |
| 2012 | 27% | +2% |
| 2011 | 25% | +2% |
| 2010 | 23% | +3% |
| 2009 | 20% | +2% |
| 2008 | 18% | +2% |
| 2007 | 16% | +2% |
| 2006 | 14% | +1% |
| 2005 | 13% | +1% |
| 2004 | 12% | +3% |
| 2003 | 9% | +2% |
| 2002 | 7% | +3% |
| 2001 | 4% | +2% |
| 2000 | 2% |